Catálogo de publicaciones - revistas

<jats:p>The Swiss drug company Roche announced last week that it is stepping away from research in RNA interference, a popular approach to medical therapies and one that Roche has poured more than $400 million into over 3 years.</jats:p>

<jats:p> <jats:italic>Science</jats:italic> Insider reported this week that the British government has apologized for postmortem research done on nuclear plant workers without proper consent in a report that blames British pathologists for ethical lapses in scores of research projects carried out from the 1950s to the early 1990s, among other stories. </jats:p>

<jats:p>In September, paleontologists launched the first systematic excavation at Majiashan quarry, north of Chaohu City in central China's Anhui Province. The dig's first fruits—including an ancestor of the plesiosaurs—are already generating a buzz.</jats:p>

<jats:p> <jats:italic>Science</jats:italic> NOW reported this week that a new analysis finds that evolutionary history, not diet, determines the makeup of our intestinal bugs; a spacecraft has successfully returned asteroid dust; and fish sleep soundly in mucous cocoons; among other stories. </jats:p>

<jats:p>The National Institutes of Health will likely dissolve its two institutes that study drug and alcohol abuse and combine their programs, according to a statement last week from Director Francis Collins.</jats:p>

<jats:p>A presidential bioethics commission concluded this week that the U.S. government should not clamp down too hard on research on synthetic biology, a young field that it says doesn't yet pose serious risks.</jats:p>

<jats:p>Researchers who've examined preserved samples of cerebral cortex from humans and several species of ape report that in a particular region of the prefrontal cortex, neurons have more space between them in the human brain than in the brains of apes, allowing more room for connections between neurons.</jats:p>

<jats:p>Our guts and airways are awash in bacteria—but people with asthma have a different balance of microbes. Could this be a cause of disease?</jats:p>

<jats:p>A group of scientists is on the verge of winning its battle to protect an Ecuadorian forest containing record biodiversity—but will the world pay to seal the innovative deal?</jats:p>

<jats:p>Reprogrammed cells from hundreds of patients are giving scientists the chance to model disease in new ways and are catching on among big pharma as well.</jats:p>